NRX Pharmaceuticals (NRXP) Treasury Shares (2017 - 2026)

NRX Pharmaceuticals (NRXP) posted quarterly Treasury Shares of $32895.0 for Q1 2026, little changed quarter-over-quarter from $32895.0 in Q4 2025.

NRX Pharmaceuticals (NRXP) Treasury Shares (2017 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has reported Treasury Shares for 8 consecutive years, with $32895.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $32895.0; the TTM figure through Mar 2026 stood at $32895.0 (changed N/A YoY), while the FY2025 annual figure was $32895.0, changed N/A from the prior year.
Treasury Shares steadied at $32895.0 in Q1 2026 per NRXP's latest filing, from $32895.0 in the prior quarter.
Across five years, Treasury Shares topped out at $1.0 million in Q3 2022 and bottomed at $32895.0 in Q4 2025.
Historically, Treasury Shares has averaged $456662.5 across 5 years, with a median of $124166.0 in 2023.
Annual changes were most pronounced in 2023 — Treasury Shares sank 33.33% — and 2024, when it sank 95.0%.
NRX Pharmaceuticals' Treasury Shares stood at $1.0 million in 2022, then tumbled by 87.58% to $124166.0 in 2023, then sank by 73.15% to $33333.0 in 2024, then dropped by 1.31% to $32895.0 in 2025, then changed by 0.0% to $32895.0 in 2026.
Business Quant data shows NRXP's Treasury Shares at $32895.0 in Q1 2026, $32895.0 in Q4 2025, and $33333.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	NRX Pharmaceuticals	132.53 Mn	105.83 Mn	426,000.00	-

Download Data